Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
RVMD Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/rvmd/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Revolution Medicines, Inc. (RVMD) Insider Trading

31 open-market trades reported since Jun 15, 2026: 0 purchases worth $0 and 31 sales worth $102.6M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Alan B. SandlerChief Development Officer0$02$1.34MOct 1, 2026
Jeff CisliniGeneral Counsel0$04$13.1MSep 29, 2026
Anthony ManciniSee Remarks0$06$5.32MSep 28, 2026
Elizabeth M. AndersonDirector0$01$1.96MSep 24, 2026
Mark A. GoldsmithSee Remarks0$04$22.3MSep 18, 2026
Stephen Michael KelseySee Remarks0$03$20.5MSep 18, 2026
Margaret A. HornCOO0$05$17.4MSep 18, 2026
Jack AndersCFO0$03$4.60MSep 18, 2026
Lorence H. KimDirector0$02$15.0MSep 10, 2026
Sushil PatelDirector0$01$1.05MJul 1, 2026

All trades

RVMD insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 1Sep 29Alan B. SandlerChief Development OfficerChief Development Officer▼ SELL10b5-16,309202.14$1.28M−11%Form 4 ↗
Sep 29Sep 25Jeff CisliniGeneral CounselGeneral Counsel▼ SELL10b5-1765207.32$159K−1.5%Form 4 ↗
Sep 28Sep 25Anthony ManciniSee RemarksSee Remarks▼ SELL10b5-13,121200.54$626K−7.3%Form 4 ↗
Sep 28Sep 24Anthony ManciniSee RemarksSee Remarks▼ SELL10b5-1587200.00$117K−1.5%Form 4 ↗
Sep 24Sep 22Elizabeth M. AndersonDirectorDirector▼ SELL10b5-110,143193.04$1.96M−70%Form 4 ↗
Sep 22Sep 18Anthony ManciniSee RemarksSee Remarks▼ SELL10b5-11,764196.94$347K−4.2%Form 4 ↗
Sep 18Sep 16Mark A. GoldsmithSee RemarksSee Remarks▼ SELL10b5-113,988199.24$2.79M−5.2%Form 4 ↗
Sep 18Sep 16Stephen Michael KelseySee RemarksSee Remarks▼ SELL10b5-15,569199.24$1.11M−1.9%Form 4 ↗
Sep 18Sep 16Margaret A. HornCOOCOO▼ SELL10b5-14,967199.24$990K−3.2%Form 4 ↗
Sep 18Sep 16Jack AndersCFOCFO▼ SELL10b5-14,053199.24$808K−3.3%Form 4 ↗
Sep 18Sep 16Jeff CisliniGeneral CounselGeneral Counsel▼ SELL10b5-13,366199.24$671K−6.0%Form 4 ↗
Sep 18Sep 16Anthony ManciniSee RemarksSee Remarks▼ SELL10b5-11,774199.24$353K−4.0%Form 4 ↗
Sep 18Sep 16Alan B. SandlerChief Development OfficerChief Development Officer▼ SELL10b5-1341199.24$68K−0.6%Form 4 ↗
Sep 15Sep 11Stephen Michael KelseySee RemarksSee Remarks▼ SELL10b5-192,531202.36$18.7M−24%Form 4 ↗
Sep 14Sep 10Anthony ManciniSee RemarksSee Remarks▼ SELL10b5-115,448204.16$3.15M−26%Form 4 ↗
Sep 10Sep 8Lorence H. KimDirectorDirector (ind.)▼ SELL10b5-117,090209.82$3.59MAll soldForm 4 ↗
Sep 2Aug 31Lorence H. KimDirectorDirector (ind.)▼ SELL10b5-156,000203.24$11.4M−77%Form 4 ↗
Aug 25Aug 21Mark A. GoldsmithSee RemarksSee Remarks▼ SELL10b5-180,000209.20$16.7M−23%Form 4 ↗
Aug 25Aug 21Jeff CisliniGeneral CounselGeneral Counsel▼ SELL10b5-156,894209.24$11.9M−50%Form 4 ↗
Aug 25Aug 21Mark A. GoldsmithSee RemarksSee Remarks (ind.)▼ SELL10b5-16,000209.20$1.26M−8.8%Form 4 ↗
Jul 1Jun 29Sushil PatelDirectorDirector▼ SELL10b5-15,580187.99$1.05M−21%Form 4 ↗
Jun 26Jun 24Jack AndersCFOCFO▼ SELL10b5-120,000168.33$3.37M−14%Form 4 ↗
Jun 18Jun 16Mark A. GoldsmithSee RemarksSee Remarks▼ SELL10b5-110,020156.12$1.56M−3.6%Form 4 ↗
Jun 18Jun 16Anthony ManciniSee RemarksSee Remarks▼ SELL4,615156.12$720K−8.5%Form 4 ↗
Jun 18Jun 16Stephen Michael KelseySee RemarksSee Remarks▼ SELL10b5-14,175156.12$652K−1.4%Form 4 ↗
Jun 18Jun 16Jack AndersCFOCFO▼ SELL10b5-12,722156.12$425K−2.2%Form 4 ↗
Jun 18Jun 16Jeff CisliniGeneral CounselGeneral Counsel▼ SELL10b5-12,157156.12$337K−3.7%Form 4 ↗
Jun 17Jun 15Margaret A. HornCOOCOO▼ SELL10b5-160,400160.17$9.67M−28%Form 4 ↗
Jun 17Jun 17Margaret A. HornCOOCOO▼ SELL10b5-129,600160.12$4.74M−16%Form 4 ↗
Jun 17Jun 16Margaret A. HornCOOCOO▼ SELL10b5-13,575156.12$558K−2.3%Form 4 ↗
Jun 15Jun 11Margaret A. HornCOOCOO▼ SELL10b5-110,000148.01$1.48M−5.9%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings